The uses of hematopoietic stem cell transplantation to restore the production of blood cells in cancer treatment
Hematopoietic stem cells (HSCs) are a limited group of all blood cell types. A study was performed on the spleen of mice undergoing bone marrow transplantation to determine the potential colonization of red blood cells. This bone marrow transplant has been leading in treating malignant...
| Main Authors: | , , , |
|---|---|
| Other Authors: | |
| Format: | Book Section |
| Language: | English |
| Published: |
Penerbit UTHM
2022
|
| Subjects: | |
| Online Access: | http://eprints.uthm.edu.my/7531/ http://eprints.uthm.edu.my/7531/1/8.pdf |
| _version_ | 1848889129933209600 |
|---|---|
| author | Abu Hashim, Nur Athirah Wan Zawawi, Wan Nursyahirah Othman, Siti Amira Mohammed, Elizah |
| author2 | Mohd Fauzi, Noor Akhmazillah |
| author_facet | Mohd Fauzi, Noor Akhmazillah Abu Hashim, Nur Athirah Wan Zawawi, Wan Nursyahirah Othman, Siti Amira Mohammed, Elizah |
| author_sort | Abu Hashim, Nur Athirah |
| building | UTHM Institutional Repository |
| collection | Online Access |
| description | Hematopoietic stem cells
(HSCs) are a limited group of all blood
cell types. A study was performed on
the spleen of mice undergoing bone
marrow transplantation to determine
the potential colonization of red blood
cells. This bone marrow transplant has
been leading in treating malignant
diseases. High-dose chemotherapy
with hematopoietic stem cells has
been commonly used in the diagnosis
of haematologic allegiances. This is a
clinical trial of autologous and
allogeneic transplants which takes the
latest developments in blood
progenitor cells into consideration.
Prior to transplantation, patients
underwent intensive myeloablative
chemotherapy with a "rescue" stem
cell. Autologous HSCT was performed
using hematopoietic stem cells of the
patient's own, pre-transplantation
removed and after myeloablation re�injected. This century has produced a
range of approaches and innovations
that have been used including modern
mobilization approaches and the in�vivo production of blood progenitor
cells, the use of core cord blood as
alternative cell source, and molecular
techniques that could include other
forms of purifying tumor cells from
potential autologous lists. |
| first_indexed | 2025-11-15T20:21:17Z |
| format | Book Section |
| id | uthm-7531 |
| institution | Universiti Tun Hussein Onn Malaysia |
| institution_category | Local University |
| language | English |
| last_indexed | 2025-11-15T20:21:17Z |
| publishDate | 2022 |
| publisher | Penerbit UTHM |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | uthm-75312022-08-15T03:09:55Z http://eprints.uthm.edu.my/7531/ The uses of hematopoietic stem cell transplantation to restore the production of blood cells in cancer treatment Abu Hashim, Nur Athirah Wan Zawawi, Wan Nursyahirah Othman, Siti Amira Mohammed, Elizah T Technology (General) Hematopoietic stem cells (HSCs) are a limited group of all blood cell types. A study was performed on the spleen of mice undergoing bone marrow transplantation to determine the potential colonization of red blood cells. This bone marrow transplant has been leading in treating malignant diseases. High-dose chemotherapy with hematopoietic stem cells has been commonly used in the diagnosis of haematologic allegiances. This is a clinical trial of autologous and allogeneic transplants which takes the latest developments in blood progenitor cells into consideration. Prior to transplantation, patients underwent intensive myeloablative chemotherapy with a "rescue" stem cell. Autologous HSCT was performed using hematopoietic stem cells of the patient's own, pre-transplantation removed and after myeloablation re�injected. This century has produced a range of approaches and innovations that have been used including modern mobilization approaches and the in�vivo production of blood progenitor cells, the use of core cord blood as alternative cell source, and molecular techniques that could include other forms of purifying tumor cells from potential autologous lists. Penerbit UTHM Mohd Fauzi, Noor Akhmazillah Mohamed, Elizah Abdul Hadi, Muhammad Faris Dol Ramli, Nur Amira Murugananthan, Yuggheshinie 2022 Book Section PeerReviewed text en http://eprints.uthm.edu.my/7531/1/8.pdf Abu Hashim, Nur Athirah and Wan Zawawi, Wan Nursyahirah and Othman, Siti Amira and Mohammed, Elizah (2022) The uses of hematopoietic stem cell transplantation to restore the production of blood cells in cancer treatment. In: CHEMICAL PROCESS AND SUSTAINABILITY IN MEDICAL BIOTECHNOLOGY. Penerbit UTHM, UTHM, pp. 103-117. |
| spellingShingle | T Technology (General) Abu Hashim, Nur Athirah Wan Zawawi, Wan Nursyahirah Othman, Siti Amira Mohammed, Elizah The uses of hematopoietic stem cell transplantation to restore the production of blood cells in cancer treatment |
| title | The uses of hematopoietic stem cell transplantation to restore the production of blood cells in cancer treatment |
| title_full | The uses of hematopoietic stem cell transplantation to restore the production of blood cells in cancer treatment |
| title_fullStr | The uses of hematopoietic stem cell transplantation to restore the production of blood cells in cancer treatment |
| title_full_unstemmed | The uses of hematopoietic stem cell transplantation to restore the production of blood cells in cancer treatment |
| title_short | The uses of hematopoietic stem cell transplantation to restore the production of blood cells in cancer treatment |
| title_sort | uses of hematopoietic stem cell transplantation to restore the production of blood cells in cancer treatment |
| topic | T Technology (General) |
| url | http://eprints.uthm.edu.my/7531/ http://eprints.uthm.edu.my/7531/1/8.pdf |